Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Nakagawa, Takayuki ^a   Suzuki, Yuichi ^a   Nagayasu, Kazuki ^a   Kitaichi, Maiko ^a   Shirakawa, Hisashi ^a   Kaneko, Shuji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; COCAINE; DOPAMINE; METHAMPHETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TYROSINE 3 MONOOXYGENASE; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITOR; PROPIDIUM IODIDE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; COCULTURE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG REEXPOSURE; EXTRACELLULAR SPACE; FEMALE; MALE; MEDIAL PREFRONTAL CORTEX; MESOLIMBIC DOPAMINERGIC SYSTEM; NEURITE; NONHUMAN; NUCLEUS ACCUMBENS; PERIKARYON; PREFRONTAL CORTEX; RAT; VENTRAL TEGMENTUM; ANIMAL; DRUG ANTAGONISM; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; METABOLISM; METHODOLOGY; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS; RODENTIA;

ANIMALS; COCAINE; COCULTURE TECHNIQUES; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; METHAMPHETAMINE; MORPHINE; NEURONS; PROPIDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 80053580697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024865     Document Type: Article

References (44)

1. Robinson TE, Berridge KC, (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291.
2. Pierce RC, Kumaresan V, (2006) The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30: 215-238.
3. Fischer JR, Cho AK, (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208: 203-209.
4. Nestler EJ, (1992) Molecular mechanisms of drug addiction. J Neurosci 12: 2439-2450.
5. Kalivas PW, Duffy P, (1988) Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem 50: 1498-1504.
6. Robinson TE, Jurson PA, Bennett JA, Bentgen KM, (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462: 211-222.
7. Kolta MG, Shreve P, Uretsky NJ, (1989) Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Neuropharmacology 28: 9-14.
8. Paulson PE, Robinson TE, (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19: 56-65.
9. Hedou G, Homberg J, Feldon J, Heidbreder CA, (2001) Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 40: 366-382.
10. Wu WR, Li N, Sorg BA, (2003) Prolonged effects of repeated cocaine on medial prefrontal cortex dopamine response to cocaine and a stressful predatory odor challenge in rats. Brain Res 991: 232-239.
11. Vanderschuren LJ, Kalivas PW, (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151: 99-120.
12. Vezina P, (2004) Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27: 827-839.
13. Sorg BA, Davidson DL, Kalivas PW, Prasad BM, (1997) Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 281: 54-61.
14. Chefer VI, Morón JA, Hope B, Rea W, Shippenberg TS, (2000) Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience 101: 619-627.
15. Williams JM, Steketee JD, (2005) Time-dependent effects of repeated cocaine administration on dopamine transmission in the medial prefrontal cortex. Neuropharmacology 48: 51-61.
16. Kalivas PW, Duffy P, Barrow J, (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251: 378-387.
17. Kitai ST, Shepard PD, Callaway JC, Scroggs R, (1999) Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 9: 690-697.
18. Karler R, Calder LD, Chaudhry IA, Turkanis SA, (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45: 599-606.
19. Schmidt HD, Pierce RC, (2010) Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann NY Acad Sci 1187: 35-75.
20. Giros B, Caron MG, (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14: 43-49.
21. Han DD, Gu HH, (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6.
22. Rougé-Pont F, Abrous DN, Le Moal M, Piazza PV, (1999) Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists. Eur J Neurosci 11: 2343-2350.
23. Peris J, Zahniser NR, (1989) Persistent augmented dopamine release after acute cocaine requires dopamine receptor activation. Pharmacol Biochem Behav 32: 71-76.
24. Gifford AN, Park MH, Kash TL, Herman LM, Park EH, et al. (2000) Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices. Naunyn-Schmiedeberg's Arch Pharmacol 362: 413-438.
25. Good CH, Lupica CR, (2010) Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs. J Neurosci 30: 7900-7909.
26. Maeda T, Fukazawa Y, Shimizu N, Ozaki M, Yamamoto H, et al. (2004) Electrophysiological characteristic of corticoaccumbens synapses in rat mesolimbic system reconstructed using organotypic slice cultures. Brain Res 1015: 34-40.
27. Fallon JH, Moore RY, (1978) Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J Comp Neurol 180: 545-580.
28. Sesack SR, Deutch AY, Roth RH, Bunney BS, (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290: 213-242.
29. Torres GE, Gainetdinov RR, Caron MG, (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4: 13-25.
30. Rudnick G, Wall SC, (1992) The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci U S A 89: 1817-1821.
31. White SR, Obradovic T, Imel KM, Wheaton MJ, (1996) The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49: 455-479.
32. Kita T, Wagner GC, Nakashima T, (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92: 178-195.
33. Cadet JL, Krasnova IN, (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88: 101-119.
34. Cass WA, Manning MW, Dugan MT, (1998) Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats. Neurosci Lett 248: 175-178.
35. Ryan LJ, Martone ME, Linder JC, Groves PM, (1988) Cocaine, in contrast to D-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of Long-Evans rats. Life Sci 43: 1403-1409.
36. Benmansour S, Tejani-Butt SM, Hauptmann M, Brunswick DJ, (1992) Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology 106: 459-462.
37. Kim S, Westphalen R, Callahan B, Hatzidimitriou G, Yuan J, et al. (2000) Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293: 625-633.
38. Kalivas PW, (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572.
39. Ohmori T, Abekawa T, Muraki A, Koyama T, (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48: 587-591.
40. White FJ, (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19: 405-436.
41. Wolf ME, Dahlin SL, Hu XT, Xue CJ, White K, (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-d-aspartate antagonists. Neuroscience 69: 417-439.
42. Cador M, Bjijou Y, Cailhol S, Stinus L, (1999) D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94: 705-721.
43. Higuchi M, Suzuki Y, Yatani Y, Kitagawa Y, Nagayasu K, et al. (2008) Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons. J Neurochem 106: 2410-2420.
44. Paxinos G, Tork I, Tecott LH, Valentino KL, (1991) Atlas of the Developing Rat Brain. Academic Press, San Diego.